Flavonoids and Cancer Prevention: A Review of the Evidence

Journal of Nutrition in Gerontology and Geriatrics

Volumn 31, Issue 3, 2012, Pages 206-238

  Romagnolo, Donato F ^a   Selmin, Ornella I ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

cancer; diet; epidemiology; flavonoids; mechanisms of action; prevention

Indexed keywords

FLAVONOID; PLANT EXTRACT;

ARTICLE; DIET; HUMAN; NEOPLASM; PHYTOTHERAPY;

DIET; FLAVONOIDS; HUMANS; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84865072242     PISSN: 21551197     EISSN: 21551200     Source Type: Journal    
DOI: 10.1080/21551197.2012.702534     Document Type: Article

References (171)

1. Yao LH, Jiang YM, Shi J, Tomás-Barberán FA, Datta N, Singanusong R, Chen SS. Flavonoids in food and their health benefits. Plant Foods Hum Nutr. 2004; 59 (3): 113-22.
2. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003; (10): 768-80.
3. Heiss C, Keen CL, Kelm M. Flavanols and cardiovascular disease prevention. Eur Heart J. 2010; (21): 2583-92.
4. Kris-Etherton PM, Lefevre M, Beecher GR, Gross MD, Keen CL, Etherton TD. Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu Rev Nutr. 2004; 24: 511-38.
5. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002; 22: 19-34.
6. Dong JY, Qin LQ. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat. 2011; 125 (2): 315-23.
7. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer.2006; 55(1):1-12.
8. Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2009; (3): CD005004.
9. Allred CD, Allred KF, Ju YH, Clausen LM, Doerge DR, et al. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis. 2004; 25 (2): 211-8.
10. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res. 2001; 61 (13): 5045-50.
11. Rossi M, Bosetti C, Negri E, Lagiou P, La Vecchia C. Flavonoids, proanthocyanidins, and cancer risk: a network of case-control studies from Italy. Nutr Cancer. 2010; 62 (7): 871-7.
12. Garavello W, Rossi M, McLaughlin JK, Bosetti C, Negri E, et al. Flavonoids and laryngeal cancer risk in Italy. Ann Oncol. 2007; 18 (6): 1104-9.
13. Rossi M, Garavello W, Talamini R, Negri E, Bosetti C, et al. Flavonoids and the risk of oral and pharyngeal cancer: a case-control study from Italy. Cancer Epidemiol Biomarkers Prev. 2007; 16 (8): 1621-5.
14. Li N, Sun Z, Han C, Chen J. The chemopreventive effects of tea on human oral precancerous mucosa lesions. Proc Soc Exp Biol Med. 1999; 220 (4): 218-24.
15. Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, et al. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res. 2009; 2 (11): 931-41.
16. Rossi M, Garavello W, Talamini R, La Vecchia C, Franceschi S, et al. Flavonoids and risk of squamous cell esophageal cancer. Int J Cancer. 2007; 120 (7): 1560-4.
17. Rossi M, Rosato V, Bosetti C, Lagiou P, Parpinel M, et al. Flavonoids, proanthocyanidins, and the risk of stomach cancer. Cancer Causes Control. 2010; 21 (10): 1597-604.
18. Ekström AM, Serafini M, Nyrén O, Wolk A, Bosetti C, Bellocco R. Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden. Ann Oncol. 2011; 22 (2): 438-43.
19. Sasazuki S, Inoue M, Miura T, Iwasaki M, Tsugane, S. Japan Public Health Center-based Prospective Study Group. Plasma tea polyphenols and gastric cancer risk: a case-control study nested in a large population-based prospective study in Japan. Cancer Epidemiol Biomarkers Prev. 2008; 17 (2): 343-51.
20. Hara A, Sasazuki S, Inoue M, Iwasaki M, Shimazu T, et al. Japan Public Health Center-Based Prospective Study Group. Isoflavone intake and risk of gastric cancer: a population-based prospective cohort study in Japan. Am J Clin Nutr. 2012; 95 (1): 147-54.
21. Rossi M, Lugo A, Lagiou P, Zucchetto A, Polesel J, et al. Proanthocyanidins and other flavonoids in relation to pancreatic cancer: a case-control study in Italy. Ann Oncol. 2011 Nov 2. [Epub ahead of print]
22. Bobe G, Weinstein SJ, Albanes D, Hirvonen T, Ashby J, et al. Flavonoid intake and risk of pancreatic cancer in male smokers (Finland). Cancer Epidemiol Biomarkers Prev. 2008; 17 (3): 553-62.
23. Nöthlings U, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Flavonols and pancreatic cancer risk: the multiethnic cohort study. Am J Epidemiol.2007; 166(8):924-31.
24. El-Rayes BF, Philip PA, Sarkar FH, Shields AF, Ferris AM, et al. A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer. Invest New Drugs. 2011; 29 (4): 694-9.
25. Budhathoki S, Joshi AM, Ohnaka K, Yin G, Toyomura K, et al. Soy food and isoflavone intake and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. Scand J Gastroenterol. 2011; 46 (2): 165-72.
26. Akhter M, Iwasaki M, Yamaji T, Sasazuki S, Tsugane S. Dietary isoflavone and the risk of colorectal adenoma: a case-control study in Japan. Br J Cancer. 2009; 100 (11): 1812-6.
27. Rossi M, Negri E, Talamini R, Bosetti C, Parpinel M, et al. Flavonoids and colorectal cancer in Italy. Cancer Epidemiol Biomarkers Prev. 2006; 15 (8): 1555-8.
28. Kyle JA, Sharp L, Little J, Duthie GG, McNeill G. Dietary flavonoid intake and colorectal cancer: a case-control study. Br J Nutr. 2010; 103 (3): 429-36.
29. Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S. Japan Public Health Center-Based Prospective Study Group. Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study. Cancer Epidemiol Biomarkers Prev. 2008; 17 (8): 2128-35.
30. Simons CC, Hughes LA, Arts IC, Goldbohm RA, van den Brandt PA, Weijenberg MP. Dietary flavonol, flavone and catechin intake and risk of colorectal cancer in the Netherlands Cohort Study. Int J Cancer. 2009; 125 (12): 2945-52.
31. Bobe G, Sansbury LB, Albert PS, Cross AJ, Kahle L, et al. Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2008; 17 (6): 1344-53.
32. Theodoratou E, Kyle J, Cetnarskyj R, Farrington SM, Tenesa A, et al. Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16 (4): 684-93.
33. Lin J, Zhang SM, Wu K, Willett WC, Fuchs CS, Giovannucci E. Flavonoid intake and colorectal cancer risk in men and women. Am J Epidemiol. 2006; 164 (7): 644-51.
34. Shimizu M, Fukutomi Y, Ninomiya M, Nagura K, Kato T, et al. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev. 2008; 17 (11): 3020-5.
35. Adams MR, Golden DL, Williams JK, Franke AA, Register TC, Kaplan JR. Soy protein containing isoflavones reduces the size of atherosclerotic plaques without affecting coronary artery reactivity in adult male monkeys. J Nutr. 2005; 135 (12): 2852-6.
36. Govers MJ, Lapre JA, De Vries HT, Van der Meer R. Dietary soybean protein compared with casein damages colonic epithelium and stimulates colonic epithelial proliferation in rats. J Nutr. 1993; 123 (10): 1709-13.
37. Vis EH, Geerse GJ, Klaassens ES, van Boekel MA, Alink GM. Possible mechanisms behind the differential effects of soy protein and casein feedings on colon cancer biomarkers in the rat. Nutr Cancer. 2005; 51 (1): 37-44.
38. Cruz-Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, et al.Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol.2006; 4(8):1035-8.
39. Lagiou P, Rossi M, Lagiou A, Tzonou A, La Vecchia C, Trichopoulos D. Flavonoid intake and liver cancer: a case-control study in Greece. Cancer Causes Control. 2008; 19 (8): 813-8.
40. Kurahashi N, Inoue M, Iwasaki M, Tanaka Y, Mizokami M, Tsugane S; JPHC Study Group. Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population-based prospective cohort of Japanese men and women. Int J Cancer. 2009; 124 (7): 1644-9.
41. Luo H, Tang L, Tang M, Billam M, Huang T, et al. Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis. 2006; 27 (2): 262-8.
42. Heald CL, Ritchie MR, Bolton-Smith C, Morton MS, Alexander FE. Phyto-oestrogens and risk of prostate cancer in Scottish men. Br J Nutr. 2007; 98 (2): 388-96.
43. Bosetti C, Bravi F, Talamini R, Parpinel M, Gnagnarella P, et al. Flavonoids and prostate cancer risk: a study in Italy. Nutr Cancer. 2006; 56 (2): 123-7.
44. Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel, LN. Multiethnic Cohort Study. Legume and isoflavone intake and prostate cancer risk: The Multiethnic Cohort Study. Int J Cancer. 2008; 123 (4): 927-32.
45. Park SY, Wilkens LR, Franke AA, Le Marchand L, Kakazu KK, et al. Urinary phytoestrogen excretion and prostate cancer risk: a nested case-control study in the Multiethnic Cohort. Br J Cancer. 2009; 101 (1): 185-91.
46. Travis RC, Spencer EA, Allen NE, Appleby PN, Roddam AW, et al. Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer. 2009; 100 (11): 1817-23.
47. Hwang YW, Kim SY, Jee SH, Kim YN, Nam CM. Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr Cancer. 2009; 61 (5): 598-606.
48. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2000; 66 (2): 1234-40.
49. McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, Cardelli JA. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res. 2009; 2 (7): 673-82.
50. Lazarevic B, Hammarström C, Yang J, Ramberg H, Diep LM, et al. The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy. Br J Nutr. 2012 Mar 8: 1-10.
51. Caliendo G, Santagada V, Perissutti E, Severino B, Fiorino F, et al. Kallikrein-Protease Activated Receptors (PAR) Axis: an attractive target for drug development. J Med Chem. 2012; 18.
52. Fischer L, Mahoney C, Jeffcoat AR, Koch MA, Thomas BE, et al.Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia. Nutr Cancer.2004; 48(2):160-70.
53. Pendleton JM, Tan WW, Anai S, Chang M, Hou W, et al. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer. 2008; 11;8: 132.
54. deVere White RW, Tsodikov A, Stapp EC, Soares SE, Fujii H, Hackman RM. Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer. Nutr Cancer. 2010; 62 (8): 1036-43.
55. Grainger EM, Schwartz SJ, Wang S, Unlu NZ, Boileau TW, et al. A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen. Nutr Cancer. 2008; 60 (2): 145-54.
56. Messing E, Gee JR, Saltzstein DR, Kim K, diSant'Agnese A, et al. A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients. Cancer Prev Res (Phila). 2012; 5 (4): 621-30.
57. Bandera EV, King M, Chandran U, Paddock LE, Rodriguez-Rodriguez L, Olson SH. Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Women's Health. 2011; 11: 40.
58. Gates MA, Vitonis AF, Tworoger SS, Rosner B, Titus-Ernstoff L, et al. Flavonoid intake and ovarian cancer risk in a population-based case-control study. Int J Cancer. 2009; 124 (8): 1918-25.
59. Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, Hankinson SE. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer. 2007; 121 (10): 2225-32.
60. Rossi M, Negri E, Lagiou P, Talamini R, Dal Maso L, et al. Flavonoids and ovarian cancer risk: a case-control study in Italy. Int J Cancer. 2008; 123 (4): 895-8.
61. Ollberding NJ, Lim U, Wilkens LR, Setiawan VW, Shvetsov YB, et al. Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study. J Natl Cancer Inst. 2012; 104 (1): 67-76.
62. Bandera EV, Williams MG, Sima C, Bayuga S, Pulick K, et al. Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control. 2009; 20 (7): 1117-27.
63. Wang Q, Li H, Tao P, Wang YP, Yuan P, et al. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China. DNA Cell Biol. 2011; 30 (8): 585-95.
64. Cho YA, Kim J, Park KS, Lim SY, Shin A, Sung MK, Ro J. Effect of dietary soy intake on breast cancer risk according to menopause and hormone receptor status. Eur J Clin Nutr. 2010; 64 (9): 924-32.
65. Iwasaki M, Hamada GS, Nishimoto IN, Netto MM, Motola, J Jr, et al.Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians. Cancer Sci.2009; 100(5):927-33.
66. Iwasaki M, Hamada GS, Nishimoto IN, Netto MM, Motola, J Jr, et al. Dietary isoflavone intake and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Breast Cancer Res Treat. 2009; 116 (2): 401-11.
67. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, et al. Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol. 2007; 165 (5): 514-23.
68. Travis RC, Allen NE, Appleby PN, Spencer EA, Roddam AW, Key TJ. A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women. Int J Cancer. 2008; 122 (3): 705-10.
69. Lampe JW, Nishino Y, Ray RM, Wu C, Li W, et al. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 2007; 16 (12): 2579-86.
70. Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, et al. Japan Public Health Center-based prospective study group. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group. J Clin Oncol. 2008; 26 (10): 1677-83.
71. Lee SA, Shu XO, Li H, Yang G, Cai H, et al. Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study. Am J Clin Nutr. 2009; 89 (6): 1920-6.
72. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, et al. Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev. 2007; 16 (11): 2285-92.
73. Guha N, Kwan ML, Quesenberry, CP Jr, Weltzien EK, Castillo AL, Caan BJ. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2009; 118 (2): 395-405.
74. Yang CS, Wang H. Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res. 2011; 55 (6): 819-31.
75. Iwasaki M, Inoue M, Sasazuki S, Miura T, Sawada N, et al. Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case-control study. Breast Cancer Res Treat. 2010; 124 (3): 827-34.
76. Luo J, Gao YT, Chow WH, Shu XO, Li H, et al. Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study. Breast Cancer Res Treat. 2010; 120 (3): 693-702.
77. Maskarinec G, Takata Y, Franke AA, Williams AE, Murphy SP. A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr. 2004; 134 (11): 3089-94.
78. D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study. Menopause. 2009; 16 (2): 301-6.
79. Maskarinec G, Verheus M, Steinberg FM, Amato P, Cramer MK, et al.Various doses of soy isoflavones do not modify mammographic density in postmenopausal women. J Nutr.2009; 139(5):981-6.
80. Nikander E, Rutanen EM, Nieminen P, Wahlström T, Ylikorkala O, Tiitinen A. Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women. Fertil Steril. 2005; 83 (1): 137-42.
81. Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, et al. Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. Cancer Prev Res. 2012; 5 (2): 309-19.
82. Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab. 1999; 84 (11): 4017-24.
83. Mursu J, Nurmi T, Tuomainen TP, Salonen JT, Pukkala E, Voutilainen S. Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Cancer. 2008; 123 (3): 660-3.
84. Cutler GJ, Nettleton JA, Ross JA, Harnack LJ, Jacobs, DR Jr, et al. Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. Int J Cancer. 2008; 123 (3): 664-71.
85. Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr. 2007; 137 (5): 1244-52.
86. Zamora-Ros R, Knaze V, Luján-Barroso L, Slimani N, Romieu I, et al. Estimated dietary intakes of flavonols, flavanones and flavones in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24 hour dietary recall cohort. Br J Nutr. 2011; 106 (12): 1915-25.
87. Knaze V, Zamora-Ros R, Luján-Barroso L, Romieu I, Scalbert A, et al. Intake estimation of total and individual flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr. 2011; 1-14.
88. US Department of Agriculture, Agricultural Research Service. 2007. USDA Database for the Flavonoid Content of Selected Foods, Release 2.1. Nutrient Data Laboratory Home Page. Accessed at http://www.ars.usda.gov/nutrientdata on 17 June 2012.
89. Zheng J, Yang B, Huang T, Yu Y, Yang J, Li D. Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies. Nutr Cancer. 2011; 63 (5): 663-72.
90. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis. 2006; 27 (7): 1310-5.
91. Seely D, Mills EJ, Wu P, Verma S, Guyatt GH. The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr Cancer Ther. 2005; 4 (2): 144-55.
92. Tang N, Wu Y, Zhou B, Wang B, Yu R. Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer. 2009; 65 (3): 274-83.
93. Nagle CM, Olsen CM, Bain CJ, Whiteman DC, Green AC, Webb PM. Tea consumption and risk of ovarian cancer. Cancer Causes Control. 2010; 21 (9): 1485-91.
94. Butler LM, Wu AH. Green and black tea in relation to gynecologic cancers. Mol Nutr Food Res. 2011; 55 (6): 931-40.
95. Sing MF, Yang WS, Gao S, Gao J, Xiang YB. Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis. Eur J Cancer Prev.2011; 20(3):157-65.
96. Kang H, Rha SY, Oh KW, Nam CM. Green tea consumption and stomach cancer risk: a meta-analysis. Epidemiol Health. 2010; 26;32: e2010001.
97. Braem MG, Onland-Moret NC, Schouten LJ, Tjonneland A, Hansen L, et al. Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis. Am J Clin Nutr. 2012; 95 (5): 1172-81.
98. Zhou B, Yang L, Wang L, Shi Y, Zhu H, Tang N, Wang B. The association of tea consumption with ovarian cancer risk: a metaanalysis. Am J Obstet Gynecol. 2007; 197 (6): 594.e1-6.
99. Steevens J, Schouten LJ, Verhage BA, Goldbohm RA, van den Brandt PA. Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer. 2007; 5;97 (9): 1291-4.
100. Zhou Y, Li N, Zhuang W, Liu G, Wu T, et al. Green tea and gastric cancer risk: meta-analysis of epidemiologic studies. Asia Pac J Clin Nutr. 2008; 17 (1): 159-65.
101. Myung SK, Bae WK, Oh SM, Kim Y, Ju W, et al. Green tea consumption and risk of stomach cancer: a meta-analysis of epidemiologic studies. Int J Cancer. 2009; 1;124(3):670-7. Erratum in: Int J Cancer. 2009; 15;124(6):1496.
102. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis. 2006; 27 (7): 1301-9.
103. Tang NP, Li H, Qiu YL, Zhou GM, Ma J. Tea consumption and risk of endometrial cancer: a metaanalysis. Am J Obstet Gynecol. 2009; 201 (6): 605.e1-8.
104. Boggs DA, Palmer JR, Stampfer MJ, Spiegelman D, Adams-Campbell LL, Rosenberg L. Tea and coffee intake in relation to risk of breast cancer in the Black Women's Health Study. Cancer Causes Control. 2010; 21 (11): 1941-8.
105. Chow HH, Hakim IA. Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res. 2011; 64 (2): 105-12.
106. Orner GA, Dashwood WM, Blum CA, Diaz GD, Li Q, Dashwood RH. Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis. 2003; 24 (2): 263-7.
107. Whitsett T, Carpenter M, Lamartiniere CA. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J Carcinog. 2006; 15: 5-15.
108. Kim M, Murakami A, Miyamoto S, Tanaka T, Ohigashi H. The modifying effects of green tea polyphenols on acute colitis and inflammation-associated colon carcinogenesis in male ICR mice. Biofactors. 2010; 36 (1): 43-51.
109. Ong CS, Zhou J, Ong CN, Shen HM. Luteolin induces G1 arrest in humanasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway. Cancer Lett. 2010; 298 (2): 167-75.
110. Han H, Zhong C, Zhang X, Liu R, Pan M, et al. Genistein induces growth inhibition and G2/M arrest in nasopharyngeal carcinoma cells. Nutr Cancer. 2010; 62 (5): 641-7.
111. Ong CS, Tran E, Nguyen TT, Ong CK, Lee SK, et al.Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in bad and hypophosphorylated retinoblastoma expressions. Oncol Rep.2004; 11(3):727-33.
112. Lim YC, Park HY, Hwang HS, Kang SU, Pyun JH, et al. (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett. 2008; 271 (1): 140-52.
113. Zhu BH, Chen HY, Zhan WH, Wang CY, Cai SR, et al. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. World J Gastroenterol. 2011; 17 (18): 2315-25.
114. Onoda C, Kuribayashi K, Nirasawa S, Tsuji N, Tanaka M, et al. (-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression. Int J Oncol. 2011; 38 (5): 1403-8.
115. Tanaka T, Ishii T, Mizuno D, Mori T, Yamaji R, et al. (-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68. Free Radic Biol Med. 2011; 50 (10): 1324-35.
116. Zikri NN, Riedl KM, Wang LS, Lechner J, Schwartz SJ, Stoner GD. Black raspberry components inhibit proliferation, induce apoptosis, and modulate gene expression in rat esophageal epithelial cells. Nutr Cancer. 2009; 61 (6): 816-26.
117. Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res. 2005; 65 (6): 2076-81.
118. Johnson JL, Rupasinghe SG, Stefani F, Schuler MA, Gonzalez de Mejia E. Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity. J Med Food. 2011; 14 (4): 325-33.
119. Phillips PA, Sangwan V, Borja-Cacho D, Dudeja V, Vickers SM, Saluja AK. Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. Cancer Lett. 2011; 308 (2): 181-8.
120. Melstrom LG, Salabat MR, Ding XZ, Milam BM, Strouch M, et al. Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells. Pancreas. 2008; 37 (4): 426-31.
121. Shin DY, Lu JN, Kim GY, Jung JM, Kang HS, et al. Anti-invasive activities of anthocyanins through modulation of tight junctions and suppression of matrix metalloproteinase activities in HCT-116 human colon carcinoma cells. Oncol Rep. 2011; 25 (2): 567-2.
122. Lee YK, Lee WS, Kim GS, Park OJ. Anthocyanins are novel AMPKα1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation. Oncol Rep. 2010; 24 (6): 1471-7.
123. Murphy EA, Davis JM, McClellan JL, Carmichael MD. Quercetin's effects on intestinal polyp multiplicity and macrophage number in the Apc(Min/+) mouse. Nutr Cancer. 2011; 63 (3): 421-6.
124. Shimizu M, Shirakami Y, Sakai H, Adachi S, Hata K, et al.(-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice. Cancer Prev Res.2008; 1(4):298-304.
125. Gu Y, Zhu CF, Dai YL, Zhong Q, Sun B. Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma. World J Gastroenterol. 2009; 15 (39): 4952-7.
126. Chodon D, Ramamurty N, Sakthisekaran D. Preliminary studies on induction of apoptosis by genistein on HepG2 cell line. Toxicol In Vitro. 2007; 21 (5): 887-91.
127. Gupta C, Tripathi DN, Vikram A, Ramarao P, Jena GB. Quercetin inhibits diethylnitrosamine-induced hepatic preneoplastic lesions in rats. Nutr Cancer. 2011; 63 (2): 234-41.
128. Bishayee A, Thoppil RJ, Mandal A, Darvesh AS, Ohanyan V, et al. Black currant phytoconstituents exert chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis by suppression of the inflammatory response. Mol Carcinog. 2011 Dec 27. [Epub ahead of print]
129. Senthilkumar K, Arunkumar R, Elumalai P, Sharmila G, Gunadharini DN, et al. Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochem Funct. 2011; 29 (2): 87-95.
130. Hsieh TC, Wu JM. Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin. Anticancer Res. 2009; 29 (10): 4025-32.
131. Kim YH, Lee YJ. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation. J Cell Biochem. 2007; 100 (4): 998-1009.
132. Tang SN, Singh C, Nall D, Meeker D, Shankar S, Srivastava RK. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J Mol Signal. 2010; 5: 14.
133. Luo H, Jiang BH, King SM, Chen YC. Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr Cancer. 2008; 60 (6): 800-9.
134. Hu XW, Meng D, Fang J. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis. 2008; 29 (12): 2369-76.
135. Hooper L, Madhavan G, Tice JA, Leinster SJ, Cassidy A. Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update. 2010; 16 (6): 745-60.
136. Setchell KD, Brown NM, Zhao X, Lindley SL, Heubi JE, et al. Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk. Am J Clin Nutr. 2011; 94 (5): 1284-94.
137. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, et al. Soy food intake and breast cancer survival. JAMA. 2009; 302 (22): 2437-43.
138. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006; 98 (7): 459-71.
139. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008; 98 (1): 9-14.
140. Li F, Ye L, Lin SM, Leung LK. Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7. Mol Cell Endocrinol.2011; 344(1-2):51-8.
141. Chou CC, Yang JS, Lu HF, Ip SW, Lo C, et al. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch Pharm Res. 2010; 33 (8): 1181-91.
142. Chen J, Zeng J, Xin M, Huang W, Chen X. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm Metab Res. 2011; 43 (10): 681-6.
143. Xiao X, Shi D, Liu L, Wang J, Xie X, et al. Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PLoS One. 2011; 6 (8): e22934.
144. Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR, Helferich WG. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J Nutr. 2001; 131 (11): 2957-62.
145. Bosviel R, Dumollard E, Déchelotte P, Bignon YJ, Bernard-Gallon D. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? OMICS. 2012; 16(5):235-44.
146. Allred CD, Twaddle NC, Allred KF, Goeppinger TS, Churchwell MI, et al. Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice. J Agric Food Chem. 2005; 53 (22): 8542-50.
147. Wang H, Bian S, Yang CS. Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α. Carcinogenesis. 2011; 32 (12): 1881-9.
148. Hess D, Igal RA. Genistein downregulates de novo lipid synthesis and impairs cell proliferation in human lung cancer cells. Exp Biol Med (Maywood). 2011; 236 (6): 707-13.
149. Zhao Y, Yang G, Ren D, Zhang X, Yin Q, Sun X. Luteolin suppresses growth and migration of human lung cancer cells. Mol Biol Rep. 2011; 38 (2): 1115-9.
150. Yan J, Wang Q, Zheng X, Sun H, Zhou Y, Li D, et al. Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model. Biochem Biophys Res Commun. 2012; 417 (2): 842-6.
151. Bruno A, Siena L, Gerbino S, Ferraro M, Chanez P, et al. Apigenin affects leptin/leptin receptor pathway and induces cell apoptosis in lung adenocarcinoma cell line. Eur J Cancer. 2011; 47 (13): 2042-51.
152. Kresty LA, Howell AB, Baird M. Cranberry proanthocyanidins mediate growth arrest of lung cancer cells through modulation of gene expression and rapid induction of apoptosis. Molecules. 2011; 16 (3): 2375-90.
153. Jin CY, Park C, Hwang HJ, Kim GY, Choi BT, et al. Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells. Mol Nutr Food Res. 2011; 55 (2): 300-9.
154. Zheng SY, Li Y, Jiang D, Zhao J, Ge JF. Anticancer effect and apoptosis induction by quercetin in the human lung cancer cell line A-549. Mol Med Report.2012; 5(3):822-6.
155. Tang NP, Zhou B, Wang B, Yu RB, Ma J. Flavonoids intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol. 2009; 39 (6): 352-9.
156. Franke AA, Hebshi SM, Pagano I, Kono N, Mack WJ, Hodis HN. Urine accurately reflects circulating isoflavonoids and ascertains compliance during soy intervention. Cancer Epidemiol Biomarkers Prev. 2010; 19 (7): 1775-83.
157. Radtke J, Linseisen J, Wolfram G. Fasting plasma concentrations of
158. Cao J, Zhang Y, Chen W, Zhao X. The relationship between fasting plasma concentrations of selected flavonoids and their ordinary dietary intake. Br J Nutr. 2010; 103 (2): 249-55.
159. Bolca S, Urpi-Sarda M, Blondeel P, Roche N, Vanhaecke L, et al. Disposition of soy isoflavones in normal human breast tissue. Am J Clin Nutr. 2010; 91 (4): 976-84.
160. U.S. Department of Agriculture, Agricultural Research Service. 2011. USDA Database for the Flavonoid Content of Selected Foods, Release 3.0. Nutrient Data Laboratory Home Page. Accessed at http://www.ars.usda.gov/nutrientdata/flav on 17 June 2012.
161. U.S. Department of Agriculture, Agricultural Research Service. 2008. USDA Database for the Isoflavone Content of Selected Foods, Release 2.0. Nutrient Data Laboratory Home Page. Accessed at http://www.ars.usda.gov/nutrientdata/isoflav on 17 June 2012.
162. U.S. Department of Agriculture, Agricultural Research Service. 2004. USDA Database for the Proanthoycanidin Content of Selected Foods. Nutrient Data Laboratory Home Page. Accessed at http://www.nal.usda.gov/fnic/foodcomp on 17 June 2012.
163. Neveu V, Perez-Jiménez J, Vos F, Crespy V, du Chaffaut L, et al. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford). 2010; 2010: bap024.
164. Nakamura H, Wang Y, Kurita T, Adomat H, Cunha GR, Wang Y. Genistein increases epidermal growth factor receptor signaling and promotes tumor progression in advanced human prostate cancer. PLoS One. 2011; 6 (5): e20034.
165. El Touny LH, Banerjee PP. Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res. 2009; 69 (8): 3695-703.
166. Adebamowo CA, Cho E, Sampson L, Katan MB, Spiegelman D, et al. Dietary flavonols and flavonol-rich foods intake and the risk of breast cancer. Int J Cancer. 2005; 114 (4): 628-33.
167. Jackson MD, McFarlane-Anderson ND, Simon GA, Bennett FI, Walker SP. Urinary phytoestrogens and risk of prostate cancer in Jamaican men. Cancer Causes Control. 2010; (12): 2249-57.
168. Lampe JW. Is equol the key to the efficacy of soy foods? Am J Clin Nutr. 2009; 89 (5): 1664S-7S.
169. Shanmugam MK, Kannaiyan R, Sethi G. Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer.2011; 63(2):161-73.
170. Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 2009; (6): 429-39.
171. Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao JT, et al. Dietary flavonoid intake and lung cancer--a population-based case-control study. Cancer. 2008; 112 (10): 2241-8.